Statera BioPharma share price logo

Statera BioPharma

OTC: STAB

$0.00

+0.00

(+100.00%)

Live

as on

Statera BioPharma Stock Performance

as on October 23, 2026 at 6:39 am IST

  • Day's Low

    Day's High

    $0.03
    downward going graph

    100.00%

    Downside

    14900.00%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Statera BioPharma share price movements today

Previous Close
$0.00
Open
-
Volume
203.0K
Market Cap
$7.1K
Day's Low - High
-

Statera BioPharma Historical Returns

1 Month Return
+ 100 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
-33.33 %
5 Year Return
-99.99 %

Statera BioPharma Stock Fundamentals & Key Indicators

Check Statera BioPharma market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$7.1K

EPS (TTM)

-2.613

Dividend Yield

0.00%

PE Ratio (TTM)

0

Industry PE ratio

-4.81

PEG Ratio

0.00

Return On Equity TTM

6677.48%

Statera BioPharma stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Statera BioPharma with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Statera BioPharma image
Statera BioPharma
NA$7.1K-99.99%NA0.00%0.00%

Stock Returns calculator for Statera BioPharma Stock including INR - Dollar returns

The Statera BioPharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Statera BioPharma investment value today

Current value as on today

₹1,08,158

Returns

₹8,158

(+8.16%)

Returns from Statera BioPharma Stock

₹0 (0%)

Dollar Impact

₹8,158 (+8.16%)

Statera BioPharma Quarterly Profit & Loss

All numbers in Millions USD

Mar 2019
Mar 2020
Dec 2020
Mar 2021
Jun 2021
Sep 2021
Dec 2021
Mar 2022
Jun 2022
Sep 2022
Total Revenue
-
-
0
-
-
0
1
0
0
0
Gross Profit
-
-
0
0
0
0
0
0
0
0
Operating Income
0
0
-3
-5
-6
-9
-77
-6
-2
-1
EBITDA
0
0
-3
-5
-6
-9
-9
-6
-2
-1
Interest Expense
0
0
0
0
0
3
7
1
0
1
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
0
0
-4
-5
-6
-12
-77
-7
-3
-3
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
0
0
-4
-5
-6
-12
-77
-8
-4
-5
Net Profit Margin
0.00%
0.00%
100.00%
0.00%
0.00%
50.99%
70.22%
64.56%
73.86%
74.74%

Statera BioPharma Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Total Revenue
-
-
-
-
-
Gross Profit
-
-
-
-
0
Operating Income
-5
-4
-2
-10
-98
EBITDA
-5
-4
-3
-10
-170
Interest Expense
-
-
0
1
1
Depreciation
0
0
0
0
0
Income Before Tax
-9
-3
-3
-12
-101
Income Tax Expense
0
-
0
1
72
Net Income
-9
-3
-3
-13
-174
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%

Statera BioPharma Quarterly Cash Flow

All numbers in Millions USD

Mar 2019
Mar 2020
Dec 2020
Mar 2021
Jun 2021
Sep 2021
Dec 2021
Mar 2022
Jun 2022
Sep 2022
Net Income
0
0
-4
-5
-6
-12
-77
-7
-3
-3
Operating Cash Flow
0
0
3
-2
-3
-14
-8
-3
0
0
Investing Cash Flow
-
-
0
0
0
13
0
0
-
-
Financing Cash Flow
-
0
-3
2
18
0
0
-2
0
0
Change in Cash
0
0
0
0
0
-1
-7
-6
0
0

Statera BioPharma Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Net Income
-9
-3
-3
-4
-101
Operating Cash Flow
-6
-4
0
-5
-28
Investing Cash Flow
3
3
0
0
13
Financing Cash Flow
-
0
0
5
20
Change in Cash
-2
0
0
0
6

Global Institutional Holdings in Statera BioPharma

Check out the Institutions with significant holdings in Statera BioPharma.

Funds
Holdings
UMB Bank NA
0.00%
Wells Fargo & Co
0.00%
Sandhill Capital Partners LLC
0.00%
Northern Trust Corp
0.00%
Archer Investment Corporation
0.00%
See all

About Statera BioPharma

Statera BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on developing cutting-edge immunotherapies. These novel treatments aim to address a range of serious conditions, including autoimmune disorders, neutropenia, anemia, emerging viral infections, and various cancers. This development is underpinned by a proprietary technological platform engineered to restore the body's immune system balance and re-establish overall physiological homeostasis. The company's therapeutic strategies are designed to directly stimulate patients' immune systems, specifically eliciting antigen-specific killer T-cells and antibodies to activate crucial defenses against inflammatory, infectious, and cancerous diseases. Statera BioPharma's clinical pipeline features programs such as STAT-201 for Crohn's disease, Entolimod for hematological conditions, STAT-401 for pancreatic cancer, and STAT-205 for COVID-19. The company is also actively exploring therapeutic applications for fibromyalgia and multiple sclerosis. Formerly known as Cytocom, Inc., the company officially adopted the name Statera BioPharma, Inc. in September 2021. Its operations are headquartered in Fort Collins, Colorado.
OrganisationStatera BioPharma
Headquarters4333 Corbett Drive,, Fort Collins, CO, 80525, US
IndustryBiotechnology
CEOBlake Hawley

Key Management of Statera BioPharma

Name

Title

Mr. Christopher Zosh

Executive VP of Finance, Interim Principal Financial Officer & Interim Principal Accounting Officer

Dr. Blake Hawley D.V.M., M.B.A.

Executive Chairman

FAQs

What is Statera BioPharma share price today?

Statera BioPharma share price today is $0.00 as on .

What is the 52 week high and 52 week low for Statera BioPharma share?

Statera BioPharma share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Statera BioPharma stock price today i.e. is trending at $0.00,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Statera BioPharma's market capitalisation today?

Statera BioPharma market capitalisation is $0.00T as on .

How to invest in Statera BioPharma Stock (STAB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Statera BioPharma on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Statera BioPharma Stock (STAB) from India?

Indian investors can start investing in Statera BioPharma (STAB) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Statera BioPharma stock (as per the Rupee-Dollar exchange rate as on ). Based on Statera BioPharma share’s latest price of $0.00 as on October 23, 2026 at 1:09 am IST, you will get 50000.0000 shares of Statera BioPharma. Learn more about fractional shares .

What are the returns that Statera BioPharma has given to Indian investors in the last 5 years?

Statera BioPharma stock has given -99.99% share price returns and 26.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?